Insider trading

Period: 120 months Stock: SPRY + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

150 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

150 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

150 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

150 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
150 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
150 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

150 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
15 Oct 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 3×
$1.49M 100,000 at 14.88
7.2%
Planned (10b5-1)
8 Oct 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$1.38M 100,000 at 13.83
6.9%
Planned (10b5-1)
8 Oct 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$1.38M 100,000 at 13.83
6.9%
Planned (10b5-1)
18 Sep 2024
Karas Eric Chief Commercial Officer
Sold on a plan
$140.00K 10,000 at 14.00
63.7%
Sold half or more
17 Sep 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$1.29M 100,000 at 12.93
6.7%
Planned (10b5-1)
17 Sep 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$1.29M 100,000 at 12.93
6.7%
Planned (10b5-1)
10 Sep 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$1.15M 100,000 at 11.50
6.7%
Planned (10b5-1)
10 Sep 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$1.15M 100,000 at 11.50
6.7%
Planned (10b5-1)
26 Aug 2024
Thompson Peter A. Director · indirect
Sold at will
$1.09M 83,695 at 13.00
100%
Sold half or more
26 Aug 2024
ORBIMED ADVISORS LLC Director · indirect
Sold at will
$1.09M 83,695 at 13.00
100%
Sold half or more
23 Aug 2024
Thompson Peter A. Director · indirect
Sold at will
$905.59K 69,500 at 13.03
45.4%
Not planned
23 Aug 2024
ORBIMED ADVISORS LLC Director · indirect
Sold at will
$905.59K 69,500 at 13.03
45.4%
Not planned
22 Aug 2024
Thompson Peter A. Director · indirect
Sold at will
$5.07M 391,482 at 12.94
71.9%
Sold half or more
22 Aug 2024
ORBIMED ADVISORS LLC Director · indirect
Sold at will
$5.07M 391,482 at 12.94
71.9%
Sold half or more
21 Aug 2024
Thompson Peter A. Director · indirect
Sold at will 2×
$5.53M 407,700 at 13.56
42.8%
Not planned
21 Aug 2024
ORBIMED ADVISORS LLC Director · indirect
Sold at will 2×
$5.53M 407,700 at 13.56
42.8%
Not planned
20 Aug 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 6×
$1.50M 100,000 at 15.03
6.3%
Planned (10b5-1)
20 Aug 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 6×
$1.50M 100,000 at 15.03
6.3%
Planned (10b5-1)
20 Aug 2024
Dorsey Brian Chief Operating Officer
Sold on a plan
$750.00K 50,000 at 15.00
89.2%
Sold half or more
20 Aug 2024
Scott Kathleen D. Chief Financial Officer
Sold on a plan
$200.00K 12,500 at 16.00
48.6%
Planned (10b5-1)
19 Aug 2024
Karas Eric Chief Commercial Officer
Sold on a plan
$140.00K 10,000 at 14.00
63.7%
Sold half or more
13 Aug 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 4×
$1.25M 100,000 at 12.48
6.5%
Planned (10b5-1)
13 Aug 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 4×
$1.25M 100,000 at 12.48
6.5%
Planned (10b5-1)
13 Aug 2024
Dorsey Brian Chief Operating Officer
Sold on a plan
$390.00K 30,000 at 13.00
83.3%
Sold half or more
16 Jul 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$1.14M 100,000 at 11.40
6.1%
Planned (10b5-1)
16 Jul 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$1.14M 100,000 at 11.40
6.1%
Planned (10b5-1)
9 Jul 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$961.73K 100,000 at 9.62
6.3%
Planned (10b5-1)
9 Jul 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$961.73K 100,000 at 9.62
6.3%
Planned (10b5-1)
12 Jun 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$876.66K 95,862 at 9.15
5.8%
Planned (10b5-1)
12 Jun 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$876.66K 95,862 at 9.15
5.8%
Planned (10b5-1)
11 Jun 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$37.25K 4,138 at 9.00
0.3%
Planned (10b5-1)
11 Jun 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$37.25K 4,138 at 9.00
0.3%
Planned (10b5-1)
16 May 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$807.02K 89,096 at 9.06
5.3%
Planned (10b5-1)
16 May 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$807.02K 89,096 at 9.06
5.3%
Planned (10b5-1)
15 May 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$46.56K 5,147 at 9.05
0.3%
Planned (10b5-1)
15 May 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$46.56K 5,147 at 9.05
0.3%
Planned (10b5-1)
14 May 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$51.85K 5,757 at 9.01
0.3%
Planned (10b5-1)
14 May 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$51.85K 5,757 at 9.01
0.3%
Planned (10b5-1)
7 May 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$934.37K 100,000 at 9.34
5.9%
Planned (10b5-1)
7 May 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$934.37K 100,000 at 9.34
5.9%
Planned (10b5-1)
16 Apr 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$928.01K 100,000 at 9.28
5.7%
Planned (10b5-1)
16 Apr 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$928.01K 100,000 at 9.28
5.7%
Planned (10b5-1)
9 Apr 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$927.74K 100,000 at 9.28
5.7%
Planned (10b5-1)
9 Apr 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$927.74K 100,000 at 9.28
5.7%
Planned (10b5-1)
27 Mar 2024
RA CAPITAL MANAGEMENT, L.P. Director · indirect
Bought
$4.95M 505,954 at 9.79
5.4%
26 Mar 2024
RA CAPITAL MANAGEMENT, L.P. Director · indirect
Bought
$4.37M 457,745 at 9.55
5.1%
25 Mar 2024
RA CAPITAL MANAGEMENT, L.P. Director · indirect
Bought
$3.96M 437,600 at 9.06
5.1%
25 Mar 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$869.19K 95,267 at 9.12
5.3%
Planned (10b5-1)
25 Mar 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$869.19K 95,267 at 9.12
5.3%
Planned (10b5-1)
22 Mar 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$21.13K 2,343 at 9.02
0.1%
Planned (10b5-1)
Showing 51–100 of 150. ← Newer Page 2 of 3 Older →